Biomaterial Database

[Relationships between the mutagenic and carcinogenic effects of hydrazine derivatives (author's transl)]. 1978

H Shimizu, and K Hayashi, and N Takemura

UI	MeSH Term	Description	Entries
D008297	Male		Males
D009153	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.	Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002273	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.	Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D006834	Hydrazines	Substituted derivatives of hydrazine (formula H2N-NH2).	Hydrazide
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D013329	Structure-Activity Relationship	The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.	Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381	Rats	The common name for the genus Rattus.	Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Shimizu, and K Hayashi, and N Takemura

Exploring relationships between mutagenic and carcinogenic potencies.

September 1988, Mutation research,

H Shimizu, and K Hayashi, and N Takemura

Relationships between mutagenic potency, reversion mechanism and metabolic behaviour within a class of chemicals (hydrazine derivatives).

May 1981, Cancer letters,

H Shimizu, and K Hayashi, and N Takemura

[Relationships between structure and the noradrenaline depleting effects of guanidine and amidine derivatives (author's transl)].

September 1975, Arzneimittel-Forschung,

H Shimizu, and K Hayashi, and N Takemura

[Newer antimycotics. I. Derivatives of phenyl-hydrazine (author's transl)].

June 1975, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,

H Shimizu, and K Hayashi, and N Takemura

Mutagenic-carcinogenic relationships and the role of mutagenic screening tests for carcinogenicity.

January 1976, Clinical toxicology,

H Shimizu, and K Hayashi, and N Takemura

[Hydrazine derivatives--potentially hazardous carcinogenic chemical compounds].

January 1988, Voprosy onkologii,

H Shimizu, and K Hayashi, and N Takemura

[Relationships between effects and plasma levels of clozapine (author's transl)].

January 1978, Arzneimittel-Forschung,

H Shimizu, and K Hayashi, and N Takemura

[Carcinogenic activity of various naturally occurring hydrazine derivatives].

January 1986, Voprosy onkologii,